You are leaving Medscape Education
Cancel Continue
View All
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
Latest In Urology
All U.S. Non-U.S.

Select all that apply





          Prostate Cancer 3003438 global 1 0.50 9 0.50 0.5 Roundtable 0 1
          Get the latest updates on advanced prostate cancer from the Annual GU Cancers meeting in San Francisco. Start activity
          Medscape Onsite: Prostate Cancer Updates From the Annual GU Cancers Meeting
          View Details
          Multiple Sclerosis 918 global 1 0.25 9 0.25 2 0.25 8 0.25 0.25 Clinical Brief 0 2
          A new study finds certain common conditions associated with a higher risk for incident multiple sclerosis (MS). Start activity
          Can Healthcare Professionals Look Out for Early Signs of Multiple Sclerosis?
          View Details
          Prostate Cancer 3003438 global 1 0.50 9 0.50 0.5 Commentary 0 1
          Dr Himisha Beltran discusses the use of poly(ADP-ribose) polymerase (PARP) inhibitor-based combination strategies in prostate cancer. Start activity
          Caring for the Patient With Prostate Cancer in the Veterans Affairs Network: Understanding the Utility of PARP Inhibitor-Based Combination Strategies
          View Details
          Bladder Cancer 821 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
          Do you know how emerging data on prostate cancer and bladder cancer can be integrated into patient care? Start activity
          Urologists' Perspective on New Data From ESMO: Prostate and Bladder Cancer
          View Details
          Bladder Cancer 821 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
          Are you up-to-date on how to use immunotherapeutic approaches in the treatment of bladder cancers? Start activity
          (Immuno)Therapeutically Targeting High-Risk Non-Muscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer
          View Details
          Prostate Cancer 3003438 global 1 0.75 9 0.75 0.75 Roundtable 0 1
          Did you know that limitations in treatment efficacy for metastatic castration-resistant prostate cancer can lead to disease progression and lower life expectancy? Start activity
          A Multidisciplinary Model: Overcoming Resistance Patterns to New Generation of Hormonal Therapies in Advanced Prostate Cancer
          View Details
          Curated Collections
          Curated activities and resources from our partners and committee
          You Might Like
          Because you completed the activity:
          Upcoming Events